| Company/Division name | ApiJect Systems |
| Parent company | ApiJect Systems Corporation |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| What product(s) and/or service(s) were outsourced domestically? | Manufacturing |
| Year reshoring announced: | 2022 |
| Domestically, the work will be done: | In-house |
| City reshored to: | Greater Orlando |
| State(s) reshored to: | FL |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | single-dose, prefilled syringes |
| What non-domestic negative factors made offshoring less attractive? | Supply chain interruption risk/Natural disaster risk/Political instability |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Proximity to customers/market |
| Government Incentive dollar amount: | 9.6M |
